Biotech
TORONTO, ONTARIO: TORONTO, ONTARIO -- (Marketwired) -- 08/17/16 -- Trillium Therapeutics Inc. (NASDAQ: TRIL)(TSX: TR), a clinical stage immuno-oncology company developing innovative therapies for the treatment of canc ...
ATLANTA, GA: ATLANTA, GA -- (Marketwired) -- 08/16/16 -- True Nature Holding, Inc. (OTCQB: TNTY) today announced that it has appointed Mr. Jack Healey to its Board of Directors.True Nature CEO James Driscoll stat ...
NEWTON, MA: NEWTON, MA -- (Marketwired) -- 08/15/16 -- , a leading global business information and events company, today announced the debut of , which will bring together leading pharmaceutical and biotech prof ...
NEW YORK, NY: NEW YORK, NY -- (Marketwired) -- 08/15/16 -- (NYSE MKT: IBIO), a leading provider of plant-based biotechnology for developing and manufacturing biological products, commented further today on the imp ...
BUFFALO, NY: BUFFALO, NY -- (Marketwired) -- 08/15/16 -- (NASDAQ: CBLI) today reported financial results and development progress for the second quarter ended June 30, 2016.Cleveland BioLabs reported a $(1.9) mi ...
SEATTLE, WA: Conference Call to Be Held Monday, August 15, 2016 at 4:30 pm Eastern Time ...
LYON, FRANCE: LYON, FRANCE -- (Marketwired) -- 08/12/16 -- Flamel Technologies (NASDAQ: FLML) today announced the launch of Akovaz™, its formulation of ephedrine sulfate for injection, which received approval fr ...
TORONTO, ONTARIO: On track to report clinical data from TTI-621 program at the end of 2016 IND submitted to initiate a Phase 1 trial with TTI-621 in solid tumors Cash amounted to $60.1 million (CDN) as of June 30, 2016 ...
VANCOUVER, BRITISH COLUMBIA: Initial Safety and Clinical Efficacy Data from the RCT-01 Trial is Expected to be Available for Analysis in December ...
SEATTLE, WA: SEATTLE, WA -- (Marketwired) -- 08/10/16 -- (NASDAQ: ATOS) announced today that it will provide a Company update and discuss second quarter 2016 financial results on Monday, August 15, 2016 at 4:30 ...
TORONTO, ONTARIO: TORONTO, ONTARIO -- (Marketwired) -- 08/10/16 -- Arch Biopartners, Inc., (Arch or the Company) (TSX VENTURE: ACH)(OTCBB: FOIFF) today announced it has engaged Catalent Inhalation, a division of Cata ...
SAN FRANCISCO, CA: Proprietary T-cell Redirecting Bispecific CD33/CD3 Antibody for the Treatment of AML Nears First-in-Human Study ...
LEXINGTON, MA: Three Positive Clinical Trials Announced in 2016 ...
SYDNEY, AUSTRALIA: SYDNEY, AUSTRALIA -- (Marketwired) -- 08/10/16 -- Prima BioMed Ltd (NASDAQ: PBMD) (ASX: PRR) ("Prima", the "Company"), has received notification from the Listing Qualifications De ...
HALIFAX, NOVA SCOTIA: HALIFAX, NOVA SCOTIA -- (Marketwired) -- 08/09/16 -- Immunovaccine Inc. ("Immunovaccine" or the "Company") (TSX: IMV)(OTCQX: IMMVF), a clinical-stage vaccine and immunotherapy com ...
ATLANTA, GA: ATLANTA, GA -- (Marketwired) -- 08/09/16 -- True Nature Holding, Inc. (OTCQB: TNTY) (the "Company") announces an update on its acquisition program."Over the past month we have, through ...
LEXINGTON, MA: Data Demonstrate Superiority of NS2 over Vehicle in Achieving Clinically Meaningful Improvement All NS2-Treated Patients Demonstrated Improvement During Therapy Dermal Biomarker Changes Consistent wit ...
